Gao Hanlin 4

What Happened Gao Hanlin, Chief Scientific Officer of Fulgent Genetics (FLGT), sold 1,688 shares on June 2, 2026 in open-market transactions for a total of $30,191. The reported weighted-average sale price was $17.89 per share (individual trades ranged from $17.63 to $18.10). This was a sale (S) reported to satisfy tax withholding obligations tied to RSUs that vested from a grant made on February 25, 2025.

Key Details

• Transaction date: June 2, 2026; Form 4 filed June 3, 2026 (timely filing).
• Shares sold: 1,688; weighted-average price: $17.89; total proceeds: $30,191.
• Price range across multiple trades: $17.63–$18.10 (footnote F2). F2 also notes the filer can provide detailed breakdowns on request.
• Reason for sale: tax withholding to cover taxes on vested restricted stock units from the Feb 25, 2025 grant (footnote F1).
• Shares owned after transaction: not specified in the provided filing.

Context The sale was done to meet tax-withholding obligations on vested RSUs, a common, routine insider transaction that does not necessarily signal a change in sentiment about the company. Purchases generally carry more informational weight for bullish signals; this type of sell-to-cover is typically administrative.